ICON PLC (ICLR): Price and Financial Metrics

ICON PLC (ICLR): $217.64

5.67 (+2.67%)

POWR Rating

Component Grades














  • Growth is the dimension where ICLR ranks best; there it ranks ahead of 84.17% of US stocks.
  • The strongest trend for ICLR is in Quality, which has been heading down over the past 179 days.
  • ICLR's current lowest rank is in the Quality metric (where it is better than 23.87% of US stocks).

ICLR Stock Summary

  • With a price/earnings ratio of 133.92, Icon Plc P/E ratio is greater than that of about 95.34% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of 1,267.24%, Icon Plc's debt growth rate surpasses 98.7% of about US stocks.
  • As for revenue growth, note that ICLR's revenue has grown 95.93% over the past 12 months; that beats the revenue growth of 91.45% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Icon Plc, a group of peers worth examining would be MLM, CBZ, CTRE, JBGS, and BRMK.
  • ICLR's SEC filings can be seen here. And to visit Icon Plc's official web site, go to www.iconplc.com.

ICLR Valuation Summary

  • ICLR's price/sales ratio is 4.8; this is 57.71% lower than that of the median Healthcare stock.
  • ICLR's price/earnings ratio has moved up 15.2 over the prior 217 months.
  • ICLR's price/earnings ratio has moved up 15.2 over the prior 217 months.

Below are key valuation metrics over time for ICLR.

Stock Date P/S P/B P/E EV/EBIT
ICLR 2021-08-31 4.8 7.3 40.6 33.2
ICLR 2021-08-30 4.8 7.3 40.7 33.3
ICLR 2021-08-27 4.8 7.2 40.3 33.0
ICLR 2021-08-26 4.8 7.2 40.2 32.9
ICLR 2021-08-25 4.7 7.2 40.0 32.7
ICLR 2021-08-24 4.7 7.1 39.6 32.4

ICLR Growth Metrics

    Its 3 year net income to common stockholders growth rate is now at 34.96%.
  • The year over year net cashflow from operations growth rate now stands at 16.61%.
  • Its 5 year net income to common stockholders growth rate is now at 53.02%.
ICLR's revenue has moved up $3,742,392,000 over the prior 52 months.

The table below shows ICLR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 5,480.826 829.142 153.185
2021-09-30 4,355.934 734.746 177.951
2021-06-30 3,191.311 547.741 363.862
2021-03-31 2,940.384 537.195 337.757
2020-12-31 2,797.288 568.035 332.331
2020-09-30 2,762.468 507.058 330.104

ICLR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ICLR has a Quality Grade of B, ranking ahead of 84.72% of graded US stocks.
  • ICLR's asset turnover comes in at 0.882 -- ranking 150th of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows ICLR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.882 0.292 0.489
2019-12-31 1.067 0.296 0.542
2018-12-31 1.153 0.300 0.447
2017-12-31 0.885 0.416 0.420
2016-12-31 0.940 0.423 0.403
2015-12-31 0.970 0.423 0.516

ICLR Price Target

For more insight on analysts targets of ICLR, see our ICLR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $205.14 Average Broker Recommendation 1.72 (Moderate Buy)

ICLR Stock Price Chart Interactive Chart >

Price chart for ICLR

ICLR Price/Volume Stats

Current price $217.64 52-week high $313.00
Prev. close $211.97 52-week low $199.01
Day low $210.17 Volume 245,882
Day high $218.50 Avg. volume 607,197
50-day MA $231.15 Dividend yield N/A
200-day MA $257.01 Market Cap 17.71B

ICON PLC (ICLR) Company Bio

ICON Public Limited Company provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company was founded in 1990 and is based in Dublin, Ireland.

ICLR Latest News Stream

Event/Time News Detail
Loading, please wait...

ICLR Latest Social Stream

Loading social stream, please wait...

View Full ICLR Social Stream

Latest ICLR News From Around the Web

Below are the latest news stories about Icon Plc that investors may wish to consider to help them evaluate ICLR as an investment opportunity.

Triangle's CRO industry saw a flurry of M&A activity over past year

One sign of the ever-evolving life sciences scene in the Triangle: There have been at least a dozen mergers and acquisitions that have involved either a Triangle-owned CRO or one with a major local presence in just the past year.

Yahoo | February 24, 2022

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q4 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 22, 2022

Icon PLC (ICLR) Q4 Earnings Meet Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 0% and 0.81%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 22, 2022

ICON Reports Fourth Quarter and Full Year 2021 Results

DUBLIN, February 22, 2022--ICON Reports Fourth Quarter and Full Year 2021 Results

Yahoo | February 22, 2022

Is ICON Public Limited Company (ICLR) A Smart Long-Term Invesment?

Polen Capital, an investment management firm, published its Polen Global Growth fourth quarter 2021 investor letter a copy of which can be downloaded here.

Insider Monkey | February 20, 2022

Read More 'ICLR' Stories Here

ICLR Price Returns

1-mo 3.31%
3-mo -8.63%
6-mo -19.99%
1-year -2.90%
3-year 54.46%
5-year 137.26%
YTD -29.73%
2021 58.84%
2020 13.21%
2019 33.29%
2018 15.21%
2017 49.14%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.5123 seconds.